Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in individuals from continental Africa. Their work addresses a long-standing gap by studying a population grossly underrepresented in medical research. The findings could pave the way for earlier and more accurate type 2 diabetes diagnoses, as well as treatments tailored to African populations. The study was led by Helmholtz Munich in collaboration with the Queen Mary University of London, the Technical University of Munich and the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit.